TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2024-11-13
公報種別公開国際商標公報
国際登録番号1809806
国際登録日2024-06-03
区分第5類(薬剤),第42類(科学・技術),第44類(医療・農林業)
商品役務Biological preparations for gene therapy; adeno-associated virus (aav) gene therapy preparations and pharmaceuticals; biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics.,Pharmaceutical research and development in the field of gene therapy; pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of rna-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery.,Medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, tauopathies, synucleinopathies, and neurodegenerative disease.
基礎出願番号90879826
基礎出願日2021-08-12
基礎出願国US
出願人Voyager Therapeutics, Inc.
OCRテキストVOYAGEK
OCRテキスト2VOYAGER
OCRについて
この商標をJ-PlatPatで参照する

関連商標

Orbital Therapeutics, Inc.
1か月前
Annexon, Inc.
1日前
ImmuneOncia Therapeutics, Inc.
1日前
INVENTIVA
1日前
Cohesys Inc.
1日前
MedBeat Sweden AB
1日前
FORTVITA BIOLOGICS (SINGAPORE) PTE.LTD.
1日前
Kagome Australia Pty Ltd
1日前
XENOTHERA
1日前
PPE INNOVATIONS, LLC
1日前
HuonsLab Co., Ltd.
1日前
ADM Protexin Limited
1日前
Annexon, Inc.
1日前
Annexon, Inc.
1日前
Glaxo Group Limited
1日前
GentiBio, Inc.
1日前
Orasis Pharmaceuticals Ltd.
1日前
個人
1日前
Samyang Holdings Corporation
1日前
Aker BioMarine Human Ingredients AS
Revervia
1日前
Hangzhou Yubai Biotechnology Co., Ltd.
vetwish
今日
Kagome Australia Pty Ltd
NinjinFibre
今日
Cohesys Inc.
cohesys
今日
Amorepacific Corporation
GlowBlend
今日
EXTERNA PTY LTD
EXTERNA
今日
SUMMIT THERAPEUTICS SUB INC.
SUMMITTHERAPEUTICS
今日
OLONEA LP
bacteflora
1日前
Tyra Biosciences, Inc.
1日前
Modere UK Limited
GlycoLemon
1日前
Made By Brave Limited
TRUECOLLAGEN
1日前
Adverum Technologies, Inc.
1日前
F. Hoffmann-La Roche AG
1日前
Onikoroshi, LLC
1日前
Bridgebio Pharma, Inc.
1日前
Zomedica Corp.
1日前
IDEXX Laboratories, Inc.
1日前
続きを見る